Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients |
| |
Authors: | Seeyoun Lee Eun Young Kim Seok Hyung Kang Seok Won Kim Seok-Ki Kim Keon Wook Kang Youngmee Kwon Kyung Hwan Shin Han-Sung Kang Jungsil Ro Eun Sook Lee |
| |
Affiliation: | (1) Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Madu-1-dong 809, Ilsan-gu Goyang-si, Gyeonggi-do, Korea |
| |
Abstract: | Background The aim was to prove the low identification rate of sentinel lymph node biopsy (SNB) and to determine the feasibility of replacing axillary lymph node dissection (AND) in axillary lymph node positive patients after chemotherapy. Methods From October 2001 to July 2005, 875 consecutive patients with primary operable breast cancer underwent SNB and AND. Among them, 238 received pre-operative chemotherapy. We compared the identification rate, false negative rate (FNR), negative predictive value (NPV), and accuracy of SNB in clinically node-positive patients with or without chemotherapy. Results The identification rate was significantly lower in patients received chemotherapy (77.6%) than in those not received it (97.0%) (P < 0.001). In those received the therapy, the FNR was 5.6%, the NPV was 86.8%, and the accuracy was 95.9%. In those not received therapy, the FNR was 7.4% and the accuracy was 92.6% (differences not statistically significant). Conclusion The identification rate in confirmed axillary lymph node-positive patients was significantly lower in patients received pre-operative chemotherapy, but accuracy did not differ significantly between the two groups. Thus, for patients who achieve complete axillary clearance by chemotherapy, SNB could replace AND. |
| |
Keywords: | Breast cancer Positive axillary node Pre-Operative Chemotherapy Sentinel Lymph Node Biopsy |
本文献已被 PubMed SpringerLink 等数据库收录! |
|